MC Liu

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia

W-C Lei, Bor‐Sheng Ko, C-Y Chen et al. · Leukemia · 2010 · 179 citations

Medicine, Molecular Genetics, Oncology +16

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

Liang‐In Lin, M-H Tseng, MC Liu et al. · Blood Cancer Journal · 2015 · 162 citations · Full text

Medicine, Hematology, Oncology +16

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

DJ Slamon, W. Eiermann, NJ Robert et al. · Cancer Research · 2016 · 149 citations

Medicine, Oncology, Pharmacology +17

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia

Cheng‐Hong Tsai, M-H Tseng, MC Liu et al. · Leukemia · 2016 · 109 citations

Life Sciences, Genetics, Molecular Genetics +17

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

T-C Chen, C-Y Chen, M-H Tseng et al. · Blood Cancer Journal · 2014 · 98 citations · Full text

Life Sciences, Genetics, Hematology +12